日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phenotypic heterogeneity and plasticity in colorectal cancer metastasis.

结直肠癌转移的表型异质性和可塑性

Ogden Samuel, Metic Nasrine, Leylek Ozen, Smith Elise A, Berner Alison M, Baker Ann-Marie, Uddin Imran, Buzzetti Marta, Gerlinger Marco, Graham Trevor, Kocher Hemant M, Efremova Mirjana

Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy

晚期黑色素瘤的临床和实验治疗,重点是免疫疗法

Millar, Lucy; Di Marco Barros, Rafael; Kapiris, Matthaios; Nikolaou, Christos; Gerlinger, Marco; Wu, Yin

UK cancer vaccine advance - Recognising and realising opportunities

英国癌症疫苗研发进展——认识并把握机遇

Craddock, Charles; Earwaker, Philip; Fittall, Matthew; Fontana, Elisa; Ganesh, Divya; Gerlinger, Marco; Ghafoor, Qamar; Jones, Robert P; Kunene, Victoria; Lee, Lennard; Lee, Rebecca; Lee, Siow-Ming; Linch, Mark; Little, Martin; Liu, Justin; McKenzie, Hayley; Petty, Russell; Pinato, David J; Powles, Thomas; Protheroe, Andrew; Robinson, Tim; Ross, Paul J; Shiu, Kai Keen; Spicer, James; Symeonides, Stefan; Tilby, Michael; Vimalachandran, Dale; Wang, Jenny Y; Wardley, Andrew; Winter, Helen

Resistance Management for Cancer: Lessons from Farmers

癌症耐药性管理:来自农民的经验教训

Seyedi, Sareh; Harris, Valerie K; Kapsetaki, Stefania E; Narayanan, Shrinath; Saha, Daniel; Compton, Zachary; Yousefi, Rezvan; May, Alexander; Fakir, Efe; Boddy, Amy M; Gerlinger, Marco; Wu, Christina; Mina, Lida; Huijben, Silvie; Gouge, Dawn H; Cisneros, Luis; Ellsworth, Peter C; Maley, Carlo C

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer

STELLAR-303:一项随机III期研究,评估赞扎林替尼联合阿特珠单抗治疗既往接受过治疗的转移性结直肠癌的疗效

Saeed, Anwaar; Tabernero, Josep; Parikh, Aparna; Van den Eynde, Marc; Karthaus, Meinolf; Gerlinger, Marco; Wang, Zhong; Wang, Guan; Smith, Robina; Hecht, J Randolph

Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer

肿瘤微生物群中的致病菌可预测结直肠癌切除术后的生存率

Alexander, James L; Posma, Joram M; Scott, Alasdair; Poynter, Liam; Mason, Sam E; Doria, M Luisa; Herendi, Lili; Roberts, Lauren; McDonald, Julie A K; Cameron, Simon; Hughes, David J; Liska, Vaclav; Susova, Simona; Soucek, Pavel; der Sluis, Verena Horneffer-van; Gomez-Romero, Maria; Lewis, Matthew R; Hoyles, Lesley; Woolston, Andrew; Cunningham, David; Darzi, Ara; Gerlinger, Marco; Goldin, Robert; Takats, Zoltan; Marchesi, Julian R; Teare, Julian; Kinross, James

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

一种新型分子特征可识别肾细胞癌中预后不良且对免疫疗法有独立反应的混合亚型

Büttner, Florian A; Winter, Stefan; Stühler, Viktoria; Rausch, Steffen; Hennenlotter, Jörg; Füssel, Susanne; Zastrow, Stefan; Meinhardt, Matthias; Toma, Marieta; Jerónimo, Carmen; Henrique, Rui; Miranda-Gonçalves, Vera; Kröger, Nils; Ribback, Silvia; Hartmann, Arndt; Agaimy, Abbas; Stöhr, Christine; Polifka, Iris; Fend, Falko; Scharpf, Marcus; Comperat, Eva; Wasinger, Gabriel; Moch, Holger; Stenzl, Arnulf; Gerlinger, Marco; Bedke, Jens; Schwab, Matthias; Schaeffeler, Elke

Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors

丝裂原活化蛋白激酶靶向疗法在非V600 BRAF突变肿瘤患者中的临床活性

Dankner, Matthew; Wang, Yifan; Fazelzad, Rouhi; Johnson, Benny; Nebhan, Caroline A; Dagogo-Jack, Ibiayi; Myall, Nathaniel J; Richtig, Georg; Bracht, Jillian W P; Gerlinger, Marco; Shinozaki, Eiji; Yoshino, Takayuki; Kotani, Daisuke; Fangusaro, Jason R; Gautschi, Oliver; Mazieres, Julien; Sosman, Jeffrey A; Kopetz, Scott; Subbiah, Vivek; Davies, Michael A; Groover, Anna L; Sullivan, Ryan J; Flaherty, Keith T; Johnson, Douglas B; Benedetti, Andrea; Cescon, David W; Spreafico, Anna; Zogopoulos, George; Rose, April A N

Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study

围手术期FLOT与ECF/ECX对可切除食管胃腺癌术后短期疗效的影响:倾向评分匹配研究

Moussa, Osama; Bhogal, Ricky Harminder; Malietzis, George; Fribbens, Charlotte; Starling, Naureen; Gerlinger, Marco; Watkins, David; Chau, Ian; Rao, Sheela; Cunningham, David; Allum, William H; Chaudry, Asif; Kumar, Sacheen

Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes

以问题为指导,探讨癌症发展演变,以此为框架推动癌症研究进展,并实现可持续的患者疗效。

Somarelli, Jason A; DeGregori, James; Gerlinger, Marco; Heng, Henry H; Marusyk, Andriy; Welch, Danny R; Laukien, Frank H